News

Pharmetheus is delighted to attend the American Society for Clinical Pharmacology & Therapeutics Annual Meeting in Atlanta this week.  If you are interested in discussing benefits of implementing a model-informed drug development strategy or

Concentration-QTc analysis has become a common approach for evaluating proarrhythmic risk and delayed cardiac repolarization of oncology drug candidates. Significant heart rate change has been associated with certain classes of oncology drugs

N,N-dimethyltryptamine (DMT) is a psychedelic compound, believed to have potential as a therapeutic option in depression and several other psychiatric disorders. Read about the relationship between drug exposure of DMT and the

At Pharmetheus, we believe in the power of quality education and are excited to contribute in spreading the interest and engagement in the growing field of pharmacometrics and model-informed drug development. We

Are you going to the PAGE 2023 meeting in A Coruña, Spain? Interested in communicating the impact of covariates in pharmacometrics models? Join Pharmetheus’ one-day workshop, focusing on implementation and interpretation of

Are you going to the PAGE 2023 meeting in A Coruña, Spain? Do you want to advance your knowledge in PBPK-QSP? Join Pharmetheus’ pre-conference two-day workshop focusing on how to leverage the

If you are a Ph.D. student within the field of pharmacometrics eager to sharpen your knowledge, we want to bring to your attention that our colleagues at Uppsala University will be conducting

We are looking for two new team members for our System Development Team! Pharmetheus is a motivated, dedicated, and growing group of 80+ people, currently undergoing exciting developments and we are looking